Montpellier — DEINOVE (Alternext Paris: ALDEI), a technological company that designs, develops and markets a new generation of industrial processes based on Deinococci bacteria, today announced the signing of a License Option Agreement with Génoplante Valor via INRA Transfert, a research enhancement subsidiary of the French National Institute in Agronomic Research that will cover the improvement of isoprenoid biosynthetic pathways. DEINOVE shall implement this technology in the DEINOCHEM ...This story is related to the following:Bacteria |